Get an overview about the market, regulation and trends of biotech manufacturing drugs in Brazil. Today the Brazilian government imports 100% of the products based on mAbs and it represents 10% of the products present in the list of imported products. However this 10% represents almost 40% of the government budget for this matter which is about 2 billion dollars/year. The government as well as the local companies are looking ahead to have local production of these drugs and this presentation will give an overview about this scenario. What do the regulations looks like? What are the challenges ahead? Can I transfer technology? How the authorities perceive Single Use Technology? What is the policy for clinical trials? Gain an understanding of the expectations of the local authorities and of Brazilian regulations for biotech products.